All stock reports

CHEMBONDCH evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-03T23:40:11.601978+00:00

Metrics

latest_annual_period
2026-03-31
revenue
3252930000.0
net_income
349610000.0
operating_cash_flow
82870000.0
free_cash_flow
13771000.0
total_assets
2536691000.0
total_liabilities
462463000.0
total_equity
2069875000.0
cash
121047000.0
total_debt
Not supplied
revenue_growth
0.11620557428519951
earnings_growth
0.1262374244176494
net_margin
0.10747541447249095
roe
0.16890391931879944
debt_to_equity
Not supplied
cash_conversion
0.2370355539029204
free_cash_flow_margin
0.0042334141835207026
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-9d4e1cb684971b605ec79a9efdccad019dbaaf57f473af5c78f64ea331ec0b25
Policy
stock-decisions-v1
Evidence bundle hash
e7549779f53572cfdc1952d52b81fa6544b0bd16c3e26c9055bf38bd701b6656
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: de94ddfe105688e025a43f596ff60d8a44e0b16236dec914f58aee4a16a4c0f7
  • daily-price: 23aa5ff0c4b1e7a53a666036adecb817f6ca0e08548315204db4035c62c7e7b5
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 215.81. The trailing 250-session price return was 31.53%. The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.11620557428519951. The cached financial metric roe is 0.16890391931879944.

Risks

The trailing 5-session price return was -13.54%. The trailing 20-session price return was -17.44%. The trailing 60-session price return was -8.52%. The closing price was -24.11% below its highest close in the available trailing year. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5. The cached financial metric free cash flow margin is 0.0042334141835207026.

Follow Up

Average cached traded value over twenty sessions was INR 2,137,717. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-03T23:40:11.601978+00:00 from EODHD.

Cached observations and evidence limits